Category: News

AVÉLI™ RECEIVES EXTENDED FDA CLEARANCE

Revelle Aesthetics, Inc. (Revelle) — a VC-backed Silicon Valley MedTech company — achieved an extended FDA clearance for its precision cellulite release device, Avéli™. Marking another key milestone for the Company, Avéli is now...

Read More

Revance Announces FDA Approval of DAXXIFY

Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced that the U.S. Food and Drug Administration (FDA) has approved DAXXIFY™ (DaxibotulinumtoxinA-lanm) for...

Read More
Loading